{"id":9865,"date":"2024-09-05T08:49:03","date_gmt":"2024-09-05T08:49:03","guid":{"rendered":"https:\/\/sescs.es\/?p=9865"},"modified":"2024-09-20T09:17:30","modified_gmt":"2024-09-20T09:17:30","slug":"cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i","status":"publish","type":"post","link":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/","title":{"rendered":"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I"},"content":{"rendered":"<div>\n<p><strong>Full title: <\/strong>Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I<\/p>\n<\/div>\n<div>\n<p><strong>Authors (in alphabetical order):<\/strong> Iv\u00e1n Castilla Rodr\u00edguez, Leticia Cu\u00e9llar-Pompa, Lidia Garc\u00eda P\u00e9rez, Lilisbeth Perestelo P\u00e9rez, Pilar Pinilla Dom\u00ednguez, Juan Manuel Ramos Go\u00f1i, Pedro Serrano Aguilar, Cristina Valc\u00e1rcel Nazco<\/p>\n<\/div>\n<p><strong>Contact person:<\/strong> <a href=\"mailto:juanmanuel.ramosgoni@sescs.es\">Juan Manuel Ramos Go\u00f1i<\/a><\/p>\n<p><strong>Objectives<\/strong><\/p>\n<p>To compare the efficiency of asenapine versus olanzapine (Generic Pharmaceutical Specialty &#8211; EFG) in the treatment of manic episodes in bipolar disorder type I, from both the perspective of the National Health System (SNS) and the societal perspective.<\/p>\n<ul>\n<li><a class=\"popup\" href=\"\/wp-content\/uploads\/2015\/09\/Informe-Asenapina_Enero_2012_FINAL.pdf\" target=\"\" rel=\"noopener\">Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I (in Spanish)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Full title: Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I Authors (in alphabetical order): &hellip; <\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[86,267],"tags":[],"class_list":["post-9865","post","type-post","status-publish","format-standard","hentry","category-other-reports","category-reports"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I | SESCS<\/title>\n<meta name=\"description\" content=\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I | SESCS\" \/>\n<meta property=\"og:description\" content=\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\" \/>\n<meta property=\"og:site_name\" content=\"SESCS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SESCS2018\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-05T08:49:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-20T09:17:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"956\" \/>\n\t<meta property=\"og:image:height\" content=\"507\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DifusionSESCS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:site\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DifusionSESCS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\"},\"author\":{\"name\":\"DifusionSESCS\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4\"},\"headline\":\"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I\",\"datePublished\":\"2024-09-05T08:49:03+00:00\",\"dateModified\":\"2024-09-20T09:17:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\"},\"wordCount\":129,\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"articleSection\":[\"Other reports\",\"Reports\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\",\"url\":\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\",\"name\":\"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I | SESCS\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/#website\"},\"datePublished\":\"2024-09-05T08:49:03+00:00\",\"dateModified\":\"2024-09-20T09:17:30+00:00\",\"description\":\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sescs.es\/#website\",\"url\":\"https:\/\/sescs.es\/\",\"name\":\"SESCS\",\"description\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones\",\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sescs.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sescs.es\/#organization\",\"name\":\"SESCS\",\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"url\":\"https:\/\/sescs.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"contentUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"width\":956,\"height\":507,\"caption\":\"SESCS\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SESCS2018\",\"https:\/\/x.com\/_SESCS_\",\"https:\/\/www.linkedin.com\/company\/sescs-canarias\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4\",\"name\":\"DifusionSESCS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"caption\":\"DifusionSESCS\"},\"url\":\"https:\/\/sescs.es\/en\/author\/difusionsescs\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I | SESCS","description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/","og_locale":"en_US","og_type":"article","og_title":"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I | SESCS","og_description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","og_url":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/","og_site_name":"SESCS","article_publisher":"https:\/\/www.facebook.com\/SESCS2018","article_published_time":"2024-09-05T08:49:03+00:00","article_modified_time":"2024-09-20T09:17:30+00:00","og_image":[{"width":956,"height":507,"url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","type":"image\/png"}],"author":"DifusionSESCS","twitter_card":"summary_large_image","twitter_creator":"@_SESCS_","twitter_site":"@_SESCS_","twitter_misc":{"Written by":"DifusionSESCS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/#article","isPartOf":{"@id":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/"},"author":{"name":"DifusionSESCS","@id":"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4"},"headline":"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I","datePublished":"2024-09-05T08:49:03+00:00","dateModified":"2024-09-20T09:17:30+00:00","mainEntityOfPage":{"@id":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/"},"wordCount":129,"publisher":{"@id":"https:\/\/sescs.es\/#organization"},"articleSection":["Other reports","Reports"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/","url":"https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/","name":"Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I | SESCS","isPartOf":{"@id":"https:\/\/sescs.es\/#website"},"datePublished":"2024-09-05T08:49:03+00:00","dateModified":"2024-09-20T09:17:30+00:00","description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sescs.es\/en\/cost-utility-asenapine-versus-olanzapine-bipolar-disorder-type-i\/"]}]},{"@type":"WebSite","@id":"https:\/\/sescs.es\/#website","url":"https:\/\/sescs.es\/","name":"SESCS","description":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones","publisher":{"@id":"https:\/\/sescs.es\/#organization"},"alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sescs.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sescs.es\/#organization","name":"SESCS","alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","url":"https:\/\/sescs.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/","url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","contentUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","width":956,"height":507,"caption":"SESCS"},"image":{"@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SESCS2018","https:\/\/x.com\/_SESCS_","https:\/\/www.linkedin.com\/company\/sescs-canarias\/"]},{"@type":"Person","@id":"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4","name":"DifusionSESCS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","caption":"DifusionSESCS"},"url":"https:\/\/sescs.es\/en\/author\/difusionsescs\/"}]}},"_links":{"self":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/9865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/comments?post=9865"}],"version-history":[{"count":2,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/9865\/revisions"}],"predecessor-version":[{"id":9867,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/9865\/revisions\/9867"}],"wp:attachment":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/media?parent=9865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/categories?post=9865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/tags?post=9865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}